Publication | Open Access

Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial

AsthmaNasopharyngeal MicrobiotaRespiratory DiseasesRespiratory ComplicationsPediatricsRespiratory InfectionVirologyPediatric Lung DiseaseInfectious Respiratory DiseaseInfection ControlMicrobiomeMedicineClinical Microbiology